European Heart Journal Advance Access published online on June 24, 2005
European Heart Journal, doi:10.1093/eurheartj/ehi376
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Service de Cardiologie, Université Paris-5, Faculté René Descartes, Hôpital Européen Georges Pompidou, 20 rue Leblanc, 75015 Paris, France; Equipe AVENIR et Unité INSERM 258, Hôpital Paul Brousse, Villejuif, France
* To whom correspondence should be addressed. Aims The prevalence of diabetes mellitus in industrialized countries is rapidly increasing, and diabetes is suspected to carry a particular high risk for sudden cardiac death (SCD). Methods and results We conducted a population-based case-control study at Group Health Cooperative. Cases (n = 2040) experienced out-of-hospital cardiac arrest due to heart disease between 1980 and 1994. Controls (n = 3800) were a stratified random sample of enrollees. Diabetes status was classified into four exclusive groups: (i) no diabetes, (ii) borderline, (iii) diabetes without microvascular disease (retinopathy or proteinuria), and (iv) diabetes with microvascular disease. When compared with no diabetes, we observed progressively higher risk of SCD associated with borderline diabetes [Odds ratio (OR) = 1.24 (0.98-1.57)], diabetes without microvascular disease [OR = 1.73 (1.28-2.34)], and diabetes with microvascular disease [OR = 2.66 (1.84-3.85)], after adjustment for potential confounders (P-value for trend <0.001). Higher glucose levels were also associated with the risk of SCD both in the absence and in the presence of microvascular disease. However, subjects with microvascular complications but with glucose level <7.7 mmol/L were not at significant increased risk of SCD. Conclusion These results emphasize the role of diabetes as a strong risk factor for SCD and outline the importance of glucose level at every stage of diabetes severity.
Received August 25, 2004
Revised April 20, 2005
Accepted May 19, 2005
Clinical research
Diabetes, glucose level, and risk of sudden cardiac death
2 University of Washington, Cardiovascular Research Unit, Metropolitan Park, East Tower, Seattle, WA 98101, USA
3 Equipe AVENIR et Unité INSERM 258, Hôpital Paul Brousse, Villejuif, France
Xavier Jouven, E-mail: xavier.jouven{at}egp.ap-hop-paris.fr
![]()
Abstract ![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
L. H. Young, F. J. Th. Wackers, D. A. Chyun, J. A. Davey, E. J. Barrett, R. Taillefer, G. V. Heller, A. E. Iskandrian, S. D. Wittlin, N. Filipchuk, et al. Cardiac Outcomes After Screening for Asymptomatic Coronary Artery Disease in Patients With Type 2 Diabetes: The DIAD Study: A Randomized Controlled Trial JAMA, April 15, 2009; 301(15): 1547 - 1555. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. S. Chugh, K. Reinier, T. Singh, A. Uy-Evanado, C. Socoteanu, D. Peters, R. Mariani, K. Gunson, and J. Jui Determinants of Prolonged QT Interval and Their Contribution to Sudden Death Risk in Coronary Artery Disease: The Oregon Sudden Unexpected Death Study Circulation, February 10, 2009; 119(5): 663 - 670. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Cosentino, L. Rydén, P. Francia, and L. G. Mellbin CHAPTER 14 Diabetes Mellitus and Metabolic Syndrome ESC Textbook of Cardiovascular Medicine, January 1, 2009; 2(1): med-9780199566990-chapter - med-9780199566990-chapter. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. A. Noseworthy and C. Newton-Cheh Genetic Determinants of Sudden Cardiac Death Circulation, October 28, 2008; 118(18): 1854 - 1863. [Full Text] [PDF] |
||||
![]() |
K Majamaa-Voltti, J Turkka, M-L Kortelainen, H Huikuri, and K Majamaa Causes of death in pedigrees with the 3243A>G mutation in mitochondrial DNA J. Neurol. Neurosurg. Psychiatry, February 1, 2008; 79(2): 209 - 211. [Abstract] [Full Text] [PDF] |
||||
![]() |
Authors/Task Force Members, L. Ryden, E. Standl, M. Bartnik, G. V. d. Berghe, J. Betteridge, M.-J. de Boer, F. Cosentino, B. Jonsson, M. Laakso, et al. Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: full text: The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD) Eur. Heart J. Suppl., June 1, 2007; 9(suppl_C): C3 - C74. [Full Text] [PDF] |
||||
![]() |
Authors/Task Force Members, L. Ryden, E. Standl, M. Bartnik, G. Van den Berghe, J. Betteridge, M.-J. de Boer, F. Cosentino, B. Jonsson, M. Laakso, et al. Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary: The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD) Eur. Heart J., January 1, 2007; 28(1): 88 - 136. [Full Text] [PDF] |
||||
![]() |
V. Salomaa Sweet and sour coronary heart disease: results from the China Heart Survey Eur. Heart J., November 1, 2006; 27(21): 2491 - 2492. [Full Text] [PDF] |
||||
![]() |
E. C. Stecker, C. Vickers, J. Waltz, C. Socoteanu, B. T. John, R. Mariani, J. H. McAnulty, K. Gunson, J. Jui, and S. S. Chugh Population-Based Analysis of Sudden Cardiac Death With and Without Left Ventricular Systolic Dysfunction: Two-Year Findings from the Oregon Sudden Unexpected Death Study J. Am. Coll. Cardiol., March 21, 2006; 47(6): 1161 - 1166. [Abstract] [Full Text] [PDF] |
||||






